• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素治疗依从性的多中心调查:哪些方面可以改进?

Multicentre survey on compliance with growth hormone therapy: what can be improved?

作者信息

Oyarzabal M, Aliaga M, Chueca M, Echarte G, Ulied A

机构信息

Servicio de Endocrinología Pediátrica, Hospital Virgen del Camino, Pamplona, Spain.

出版信息

Acta Paediatr. 1998 Apr;87(4):387-91. doi: 10.1080/08035259850156959.

DOI:10.1080/08035259850156959
PMID:9628292
Abstract

A survey was undertaken to evaluate compliance in Spanish patients receiving growth hormone treatment. The 28-item structured questionnaire was designed to collect data on compliance, treatment schedule, device used and instruction received. In total, 473 questionnaires were completed in 17 paediatric endocrine units. Compliance was divided into four categories based on percentage of doses omitted, classified as excellent if 0%, good <5%, fair 5-10% and poor >10%. The level of compliance was excellent in 74.0%, good in 20.1%, fair in 3.4% and poor in 2.5%. Compliance was better in those who injected themselves (p < 0.01), were trained by hospital staff (p < 0.01) and used automatic pens (p < 0.05). Patients using conventional syringes were less likely to comply (p < 0.05). More information on growth hormone treatment was requested by 57.6% of patients. The results indicate that the specialist nurse should spend sufficient time with the patients and relatives to ensure a higher compliance rate.

摘要

开展了一项调查,以评估接受生长激素治疗的西班牙患者的依从性。这份包含28个条目的结构化问卷旨在收集有关依从性、治疗方案、使用的器械和所接受指导的资料。17个儿科内分泌科室共完成了473份问卷。依从性根据漏用剂量的百分比分为四类,如果漏用率为0%则为优秀,<5%为良好,5-10%为中等,>10%为差。依从性水平优秀的占74.0%,良好的占20.1%,中等的占3.4%,差的占2.5%。自行注射的患者(p<0.01)、接受医院工作人员培训的患者(p<0.01)以及使用自动笔的患者(p<0.05)依从性更好。使用传统注射器的患者依从性较低(p<0.05)。57.6%的患者要求获取更多有关生长激素治疗的信息。结果表明,专科护士应与患者及其亲属充分交流,以确保更高的依从率。

相似文献

1
Multicentre survey on compliance with growth hormone therapy: what can be improved?生长激素治疗依从性的多中心调查:哪些方面可以改进?
Acta Paediatr. 1998 Apr;87(4):387-91. doi: 10.1080/08035259850156959.
2
Compliance with growth hormone treatment--are they getting it?生长激素治疗的依从性——他们做到了吗?
Arch Dis Child. 1993 Jan;68(1):91-3. doi: 10.1136/adc.68.1.91.
3
Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.在人生长激素治疗中,对无针Medi-Jector或多剂量Disetronic注射笔的心理反应。
Acta Paediatr. 1998 Feb;87(2):154-8. doi: 10.1080/08035259850157589.
4
Improvement of patient convenience in treatment with growth hormone.改善生长激素治疗中患者的便利性。
J Pediatr Endocrinol. 1994 Apr-Jun;7(2):175-80. doi: 10.1515/jpem.1994.7.2.175.
5
Factors associated with compliance among tuberculosis patients in Thailand.泰国结核病患者依从性的相关因素。
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S149-56.
6
Treatment with growth hormone. What do children know and how do they accept it?
Horm Res. 1995;44 Suppl 3:18-25. doi: 10.1159/000184669.
7
Patient knowledge and compliance with growth hormone treatment.患者对生长激素治疗的认知与依从性。
Arch Dis Child. 1993 Apr;68(4):525. doi: 10.1136/adc.68.4.525.
8
[Treatment of short stature in Turner syndrome with recombinant growth hormone. Multicentric study in Spain. Spanish Cooperative Group].
An Esp Pediatr. 1988 Oct;29 Suppl 35:2-4.
9
Optimizing growth hormone efficacy: an evidence-based analysis.优化生长激素疗效:一项基于证据的分析。
Horm Res. 2004;62 Suppl 3:93-7. doi: 10.1159/000080506.
10
Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.长期生长激素治疗儿童肾性低磷性佝偻病:对生长、矿物质代谢和骨密度的影响。
J Pediatr. 1995 Sep;127(3):395-402. doi: 10.1016/s0022-3476(95)70070-6.

引用本文的文献

1
A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China.聚乙二醇化重组人生长激素在中国小于胎龄儿矮小儿童中的52周2期研究。
Clin Endocrinol (Oxf). 2025 Feb;102(2):136-146. doi: 10.1111/cen.15156. Epub 2024 Nov 8.
2
Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.使用Easypod Connect监测台湾儿童生长激素治疗的依从率和生长结果:观察性研究
JMIR Pediatr Parent. 2021 Jan 15;4(1):e14774. doi: 10.2196/14774.
3
Exploring Potentially Modifiable Factors That Influence Treatment Non-Adherence Amongst Pediatric Growth Hormone Deficiency: A Qualitative Study.
探索影响儿童生长激素缺乏症治疗依从性的潜在可改变因素:一项定性研究。
Patient Prefer Adherence. 2020 Oct 13;14:1889-1899. doi: 10.2147/PPA.S268972. eCollection 2020.
4
Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).墨西哥生长激素缺乏症、小于胎龄儿和特纳综合征患儿的治疗依从性:Easypod™ connect 观察性研究(ECOS)的结果。
J Endocrinol Invest. 2020 Oct;43(10):1447-1452. doi: 10.1007/s40618-020-01218-4. Epub 2020 Apr 1.
5
Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).初治生长激素缺乏症儿童对生长激素治疗的依从性:来自 easypod connect 观察研究(ECOS)的意大利队列数据。
J Endocrinol Invest. 2019 Oct;42(10):1241-1244. doi: 10.1007/s40618-019-01046-1. Epub 2019 Apr 9.
6
Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care.生长激素治疗中的共同决策——对患者护理的影响
Front Endocrinol (Lausanne). 2018 Nov 22;9:688. doi: 10.3389/fendo.2018.00688. eCollection 2018.
7
Adherence and long-term growth outcomes: results from the easypod connect observational study (ECOS) in paediatric patients with growth disorders.依从性和长期生长结果:来自易普德连接观察性研究(ECOS)针对生长障碍儿科患者的结果
Endocr Connect. 2018 Aug;7(8):914-923. doi: 10.1530/EC-18-0172. Epub 2018 Jul 5.
8
Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.液体人生长激素(hGH)[诺德人体生长激素简易Xx®]在生长激素缺乏的成人和儿童以及慢性肾病儿童中的可接受性
Clin Drug Investig. 2002 Sep;22(9):633-638. doi: 10.2165/00044011-200222090-00008.
9
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.一种用于自行注射重组人生长激素的新型笔式装置的验证及易用性:一项双中心可用性研究的结果
Med Devices (Auckl). 2013 Sep 2;6:141-6. doi: 10.2147/MDER.S50088. eCollection 2013.
10
User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.新型预填充生长激素笔Norditropin NordiFlex(®)的用户评估:一项IV期多中心前瞻性研究。
Patient Prefer Adherence. 2013 May 24;7:455-62. doi: 10.2147/PPA.S43460. Print 2013.